Raffaele Pilla
About
In The Last Decade
Raffaele Pilla
28 papers receiving 512 citations
Peers
Comparison fields: 5 of 114
- Physiology 184
- Molecular Biology 123
- Endocrinology, Diabetes and Metabolism 61
- Clinical Biochemistry 60
- Pulmonary and Respiratory Medicine 51
Countries citing papers authored by Raffaele Pilla
This map shows the geographic impact of Raffaele Pilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raffaele Pilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raffaele Pilla more than expected).
Fields of papers citing papers by Raffaele Pilla
This network shows the impact of papers produced by Raffaele Pilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raffaele Pilla. The network helps show where Raffaele Pilla may publish in the future.
Co-authorship network of co-authors of Raffaele Pilla
This figure shows the co-authorship network connecting the top 25 collaborators of Raffaele Pilla. A scholar is included among the top collaborators of Raffaele Pilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raffaele Pilla. Raffaele Pilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 1 | |
| 3 | 8 | |
| 4 | 0 | |
| 5 | 27 | |
| 6 | 11 | |
| 7 | 25 | |
| 8 | 7 | |
| 9 | 21 | |
| 10 | 111 | |
| 11 | 3 | |
| 12 | 3 | |
| 13 | 20 | |
| 14 | 33 | |
| 15 | 48 | |
| 16 | 6 | |
| 17 | [Influence of HLA compatibility on cytomegalovirus infection in kidney transplantation]. | 10 |
| 18 | Influence of chronic cytomegalovirus and hepatitis B virus infections on the outcome of renal transplantation. | 2 |
| 19 | Prophylactic polyclonal versus monoclonal antibodies in kidney and pancreas transplantation. | 5 |
| 20 | 23 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.